ALBANY, N.Y., Jan. 10, 2014 /PRNewswire/ -- Albany Molecular Research Inc. (NASDAQ: AMRI) today announced the appointment of Vijay Kumar Batra, to the position of Managing Director, AMRI India, effective January 2, 2014. Mr. Batra will report to Steve Hagen, Ph.D., Senior Vice President of Manufacturing and Pharmaceuticals.
"Mr. Batra brings a wealth of experience in the Active Pharmaceutical Ingredients (APIs) and intermediates business and he also brings a leadership acumen that helps AMRI continue our plan for growth in the Indian and world markets," said Dr. Hagen. "We are excited to have Vijay on our leadership team. He has a strong record of leading business growth in the area of API and intermediates and is highly respected by those who have worked with him and the businesses he has led."
Before coming to AMRI, Mr. Batra held a number of executive roles with Teva Pharmaceuticals Industries Ltd. since 2003. Most recently, he was Vice Chairman and Managing Director, Teva API India, responsible for research and development and manufacturing of API's and advanced intermediates for the global market. The facilities overseen by Mr. Batra had strong compliance records and achieved U.S. Food and Drug Administration and other international certifications. Mr. Batra also served as Chairman of Teva API China during his most recent tenure. Prior to these roles, Mr. Batra was President and Director of JK Drugs and Pharmaceuticals and Advisor at JK Pharmachem Ltd. He also held other roles with Ranbaxy, Kinetics Technology India Ltd., and Synthetics and Chemicals Ltd. Mr. Batra was also responsible for Drug Product Manufacturing and was Vice Chairman of Tevapharm India Pvt. Ltd. during his last few years.
Mr. Batra earned a Bachelor's degree in Technology from the Indian Institute of Technology and is an alumnus of the Wharton Business School's Senior Executive Development program.
Albany Molecular Research, Inc. (AMRI) is a global contract research and manufacturing organization offering customers fully integrated drug discovery, development and manufacturing services. For over 22 years, AMRI has demonstrated its adaptability as the pharmaceutical and biotechnology industries have undergone tremendous change in response to multiple challenges. This experience, a track record of success and locations in the United States, Europe and Asia now provides our customers with SMARTSOURCING™, a full range of value-added opportunities providing customers with informed decision-making, enhanced efficiency and more successful outcomes at all stages of the pipeline. AMRI has also successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development. For more information about AMRI, please visit our website at www.amriglobal.com or follow us on Twitter (@amriglobal).
Copyright©2012 PR Newswire.
All rights reserved